Artio Medical, formerly known as Metactive Medical, is a medical device company developing innovative products for the peripheral vascular and neurovascular markets.
Artio Medical is committed to developing and commercializing novel, best-in-class medical devices that have the potential to provide better patient outcomes.
Artio Medical was founded in 2011 by Nicholas Franano. The company is headquartered in Fairway, Kansas, with an office in Lowell, Massachusetts.
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold™ and Solus Flex™ Embolization Devices for peripheral vessel occlusion and the Amplifi™ Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura™ Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Artio is backed by Northpoint Development, Accelerate Venture Partners, National Institutes of Health, Serra Ventures, Mid-America Angels, Kansas Bioscience Authority, and others. The company raised an additional $28M in oversubscribed Series A2 and A3 financing on Jun 16, 2022. This brings Artio's total funding to $73.4M to date.